Not Verified

Melvin Yahr Parkinson’s Disease Clinical Research Award

Parkinson's Foundation

The Melvin Yahr Parkinson’s Disease Clinical Research Award is jointly supported by the Parkinson’s Foundation and the International Association of Parkinsonism and Related Disorders (IAPRD). This award is designed to foster clinical research into any aspect of Parkinson’s disease conducted by young investigators who are under-represented in current research. By recognizing and honoring the exceptional contributions of young talented individuals, the award seeks to break down barriers and create a more inclusive and diverse healthcare community. It is expected that this initiative will spur innovation and promote the translation of cutting-edge scientific discoveries into efficient and practical health measures that will benefit people with Parkinson’s disease.

This award honors Dr. Melvin Yahr, a leader in PD care and research who, with the Foundation’s support, played a seminal role in establishing levodopa as the gold standard symptomatic therapy for PD. In addition to his groundbreaking research, Dr. Yahr also served as a champion of young neurologists, particularly women and other under-represented groups. The goal of the award is to prepare young neurologists specializing in Parkinson’s disease for a career in clinical research. Clinician scientists are uniquely positioned to be experts in both Parkinson’s disease research and care.

Level of Support

This is a 1-year award for a total of $50,000. Funds can be used to support research expenses such as salary support for additional trained personnel (e.g., research assistants, study coordinators), equipment or consumables specifically needed for the research plan. Indirect costs are not allowed.

AI Based Application Success Predictor

1. ⭐⭐⭐⭐⭐ Direct relevance to Parkinson's disease

This is the most fundamental predictor.

A proposal should make a clear connection to understanding, preventing, diagnosing, treating or improving outcomes in Parkinson's disease. The Foundation's currently funded portfolio is explicitly organized around understanding how PD affects the brain and body and using that knowledge to develop better treatments.

Strong proposals should answer:

What specific PD problem is being addressed?
Why is it important to people with PD?
What knowledge gap currently prevents progress?
How will the research advance understanding or treatment?

A generic neuroscience project with only a distant connection to PD would have weaker alignment.

2. ⭐⭐⭐⭐⭐ Innovative / high-impact scientific idea

Innovation is a major recurring feature of the Foundation's current research portfolio.

The Foundation describes its independent-investigator awards as supporting high-risk, high-reward research capable of transforming understanding of PD, establishing new research directions or accelerating novel interventions.

The 2026 Impact Award portfolio, for example, includes research on:

Oligodendrocyte progenitor cells
Autophagic secretion and neuroinflammation
UCH-L1 biology
Gut microbiota and alpha-synuclein pathology.

Success predictor: The project should offer something more than another incremental study of an already-established PD mechanism.

3. ⭐⭐⭐⭐⭐ Potential to change PD treatment, diagnosis or disease understanding

The Foundation repeatedly connects funded research to eventual improvements in therapies, treatment strategies, biomarkers, disease understanding or cure development.

Examples from funded projects include:

Understanding early alpha-synuclein accumulation to inform therapeutic strategies.
Studying brainstem circuitry as a potential alternative therapeutic target.
Developing approaches that could improve deep-brain stimulation.
Investigating mechanisms that could lead to biomarkers or new treatment strategies.

Therefore, applicants should clearly articulate the path from discovery → PD application.

4. ⭐⭐⭐⭐⭐ Strong scientific rigor and methodology

A compelling PD question is not sufficient by itself. The proposal must provide a credible way to answer it.

Important elements include:

Clear hypothesis or research question.
Appropriate experimental design.
Well-defined outcomes.
Appropriate controls.
Valid statistical methodology.
Reproducible methods.
Appropriate human/animal models where applicable.
Alternative approaches for important technical risks.

The Foundation's research awards undergo competitive peer review involving scientific experts and research advocates.

Reviewer logic:

Important PD problem + innovative hypothesis + inadequate methodology = weak proposal.

5. ⭐⭐⭐⭐⭐ Clear translational or clinical significance

The Foundation funds basic science, but the strongest proposals should explain why the discovery matters for Parkinson's patients.

This does not mean every basic-science project must immediately produce a treatment.

Rather, the applicant should establish a credible chain:

Mechanism → biological understanding → potential biomarker/target/intervention → future patient benefit

For example, Foundation-funded research has examined:

Alpha-synuclein pathology.
Microglial and inflammatory mechanisms.
Brain chemical imbalances.
Cognitive decline.
Gut microbiome.
Mitochondrial dysfunction.
DBS optimization.

6. ⭐⭐⭐⭐☆ Strong fit with the specific funding mechanism

The Foundation has multiple grant mechanisms, and each serves a different purpose.

Mechanism	Primary purpose
Impact Awards	Innovative foundational research with potential for major PD impact
Stanley Fahn Junior Faculty Award	Early-career faculty development and independent PD research
Postdoctoral Fellowships	Training the next generation of PD researchers
Launch Award	Transition toward independent research leadership
Visiting Scholar Award	Specialized training/skill development
Summer Student Fellowship	Early exposure to PD research
Clinical Research Awards	Clinical investigation and movement-disorders research
Research Centers	Institutional PD research infrastructure
Conference Awards	Expert collaboration around unresolved PD problems

A proposal should therefore be designed for the mechanism, rather than submitting essentially the same project to every Foundation program.

7. ⭐⭐⭐⭐☆ Investigator's career-stage and independence fit

Career development is a particularly important component of the Parkinson's Foundation portfolio.

The Stanley Fahn Junior Faculty Award, for example, is specifically designed to help promising early-career faculty establish independent research programs and obtain future independent funding such as an NIH R01.

The Launch Award similarly uses a mentored and independent stage to help researchers progress toward becoming independent research group leaders.

For these mechanisms, reviewers therefore assess not only:

"Is this good science?"

but also:

"Will this award meaningfully advance this investigator's independent PD research career?"

8. ⭐⭐⭐⭐☆ Clear future-funding and career-development pathway

A particularly important feature of the Foundation's early-career programs is the expectation that Foundation support will help researchers progress toward independent research careers and larger external funding.

A strong application can therefore show:

Parkinson's Foundation award
↓
Preliminary/definitive findings
↓
Publication
↓
Independent research program
↓
NIH R01 / other major external funding
↓
Larger PD research program

This is particularly relevant to the Stanley Fahn Junior Faculty and Launch mechanisms.

9. ⭐⭐⭐⭐☆ Addressing an important unmet need or underexplored aspect of PD

The Foundation's portfolio is broad because Parkinson's affects many aspects of health beyond classic motor symptoms.

Current funded research includes areas such as:

Motor dysfunction
Cognitive decline
Neuroinflammation
Alpha-synuclein
Genetics
Mitochondria
Gut-brain interactions
Microbiome
Environmental exposures
Biomarkers
Neural circuitry
DBS and other therapeutic technologies.

A proposal becomes stronger when it identifies a specific unresolved problem rather than simply studying PD broadly.

10. ⭐⭐⭐⭐☆ Feasibility, appropriate scope and measurable outcomes

High-risk research is welcomed, but the proposed work still needs to be achievable within the award's resources and duration.

A strong application should have:

Focused Specific Aims.
Realistic sample sizes.
Appropriate recruitment strategy.
Access to required equipment/data/patient populations.
Qualified collaborators.
Appropriate statistical expertise.
Defined milestones.
Clear deliverables.

For example, an early-career grant should not attempt to answer every major question about PD simultaneously.

High ambition + focused execution is preferable to high ambition + unrealistic scope.

Specialties

Neurosciences

Eligibility Requirements

Early-stage investigators based at universities, research hospitals, or non-profit research institutions worldwide are eligible to apply.

Candidates should hold an MD degree; be specialized in one of these fields: neurology, psychiatry, physical medicine and rehabilitation, or related fields; be either less than 35 years old or 5 years out of the residency program (which one best applies).

We particularly encourage applications of investigators from under-represented countries in Asia, Africa, and Latin America.

Sponsor Details

Sponsor Institute/Organizations: Parkinson's Foundation

Sponsor Type: Corporate/Non-Profit

Address: 1350 Broadway, Ste 1530, New York, NY 10018

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity